TY - JOUR
KW - Behavior, Addictive
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Systematic Reviews as Topic
KW - buprenorphine
KW - long-term
KW - opioid use disorder
KW - Retention
KW - Systematic Review
AU - A. J. Kennedy
AU - C. B. Wessel
AU - R. Levine
AU - K. Downer
AU - M. Raymond
AU - D. Osakue
AU - I. Hassan
AU - J. S. Merlin
AU - J. M. Liebschutz
A1 - 
AD - Ambulatory Care Network, Department of Health Services, Los Angeles County, Los Angeles, CA, USA.; Health Sciences Library Systems, University of Pittsburgh, Pittsburgh, PA, USA.; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.; Division of General Internal Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.; Center for Research on Health Care, Pittsburgh, PA, USA.; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA. liebschutzjm@upmc.edu.; Center for Research on Health Care, Pittsburgh, PA, USA. liebschutzjm@upmc.edu.
BT - Journal of general internal medicine
C5 - Education & Workforce; Opioids & Substance Use
CP - 2
DO - 10.1007/s11606-020-06448-z
IS - 2
JF - Journal of general internal medicine
LA - eng
M1 - Journal Article
PB - . Society of General Internal Medicine
PY - 2022
SN - 1525-1497; 0884-8734; 0884-8734
SP - 332
EP - 340
EP - 
T1 - Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic Review
T2 - Journal of general internal medicine
TI - Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic Review
U1 - Education & Workforce; Opioids & Substance Use
U2 - 33469778
U3 - 10.1007/s11606-020-06448-z
VL - 37
VO - 1525-1497; 0884-8734; 0884-8734
Y1 - 2022
Y2 - Feb
ER -